KEMET (NYSE: KEM ) is expected to report Q3 earnings on Jan. 31. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict KEMET's revenues will wane -8.3% and EPS will shrink to a loss.
The average estimate for revenue is $200.6 million. On the bottom line, the average EPS estimate is -$0.18.
Last quarter, KEMET logged revenue of $216.0 million. GAAP reported sales were 19% lower than the prior-year quarter's $265.5 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at -$0.14. GAAP EPS were -$0.55 for Q2 versus $0.27 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 15.2%, 820 basis points worse than the prior-year quarter. Operating margin was -0.9%, 1,090 basis points worse than the prior-year quarter. Net margin was -11.5%, 1,690 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $846.5 million. The average EPS estimate is -$0.61.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 120 members out of 126 rating the stock outperform, and six members rating it underperform. Among 30 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 28 give KEMET a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on KEMET is hold, with an average price target of $8.75.
Looking for alternatives to KEMET? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.